Stay updated on Interchangeability Study of ABP 654 in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Interchangeability Study of ABP 654 in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Interchangeability Study of ABP 654 in Psoriasis Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T22:05:43.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the evaluation of pharmacokinetic similarity, efficacy, safety, and immunogenicity of multiple switches between ustekinumab and ABP 654 compared with continued use of ustekinumab in participants with moderate to severe plaque psoriasis.
    Difference
    0.1%
    Check dated 2024-06-06T14:34:42.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The webpage has updated the 'Participation Criteria' section to include detailed eligibility criteria for participants, specifying conditions such as stable moderate to severe plaque psoriasis for at least 6 months and a PASI score of ≥ 12. Previously, it only mentioned that no information was provided about collaborators.
    Difference
    24%
    Check dated 2024-05-22T21:34:37.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:48:23.000Z thumbnail image

Stay in the know with updates to Interchangeability Study of ABP 654 in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Interchangeability Study of ABP 654 in Psoriasis Clinical Trial page.